For decades, Immunoglobulin G (IgG) has been the undisputed heavyweight champion of therapeutic antibodies. From treating chronic autoimmune diseases to revolutionizing oncology with immune checkpoint inhibitors, IgG molecules have dominated the biologics market. Their long serum half-life, ease of manufacturing, and well-understood biology made them the logical first choice for researchers....
Greek 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)